Clinical Trial Update: ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating ctDNA-directed post-hepatectomy chemotherapy for patients with resectable colorectal liver metastases; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Metastases | Phase 2 | Status: RECRUITING